Our new design is here! Clearer, more modern, more international. With our new design and visual language we have achieved a strong visual alignment with the corporate identity of Revvity, Inc. At the same time, we harmonized the visual appearance of the Euroimmun and IDS brands creating a new modernized look which visually reflects our shared identity and growing collaboration. But what really counts remains the same: our […]
The integration of Immunodiagnostic Systems (IDS) products into the Euroimmun portfolio has created a unique and broad menu of speciality testing solutions. Our combined chemiluminescence immunoassay (ChLIA) range now spans more than 200 analytes from six diagnostic areas: endocrinology, autoimmunity, infectious diseases, allergy, Alzheimer’s disease and therapeutic drug monitoring. ChLIAs from multiple diagnostic areas can
This milestone is much more than just a number: Every single installation stands for a laboratory that decided to leave manual processes behind and to opt for a solution that combines efficiency, safety, scalability and automation aspects. Today, the laboratory management system EUROLabOffice and its successor EUROLabOffice 4.0 are installed in more than 60 countries
With passion for rheumatology! Recently, three new fluorescence patterns were added to the classification tree of the International Consensus on Antinuclear Antibody Patterns (ICAP)1. ICAP is an initiative of international scientists with the goal of evaluating the large number of ANA patterns in a standardised way. ANA (antinuclear antibodies) are biomarkers for different autoimmune diseases,
Vesicular glutamate transporter 2 (VGLUT2) has been identified as a novel target antigen of autoantibodies in patients with neurological disorders, frequently accompanied by comorbidities with cardiovascular and inflammatory involvement. The discovery was made in a collaborative study between Euroimmun and different laboratories and clinics in Germany, which was published recently in the journal Brain, Behavior,
